Mental Health News and Research

Latest Mental Health News and Research

Substance abuse treatment facilities offering nicotine replacement therapy increased by 6%: Report

The percentage of substance abuse treatment facilities offering nicotine replacement therapy to clients gradually increased by about 6 percentage points from 2006 to 2009, according to a new Spotlight report issued by the Substance Abuse and Mental Health Services Administration released in conjunction with the "Great American Smokeout."

19 Nov 2010

SAMHSA: 4.8% U.S. adults suffer from serious mental illness

According to new results from a national survey, 19.9 percent of American adults in the United States (45.1 million) have experienced mental illness over the past year. The survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 11 million adults (4.8 percent) in the U.S. suffered serious mental illness in the past year a diagnosable mental disorder has substantially interfered with, or limited one or more major life activities.

19 Nov 2010

Illness perception related to concurrent depression symptoms: Research

New research findings which highlight the detrimental effect of depression on patients with end-stage kidney disease has celebrated at the University of Hertfordshire 2010 Awards Ceremonies yesterday (17 November 2010) at the Cathedral and Abbey Church of St Alban.

19 Nov 2010

Experts formulate research related to psychological adjustment and traumatic brain injury

Five U.S. federal agencies recently cosponsored a set of expert work groups to formulate common data elements for research related to psychological adjustment and traumatic brain injury (TBI).

19 Nov 2010

Ridge announces data from Clinical Experience Program on blood test for MDD disorder

Ridge Diagnostics, Inc., a neurodiagnostic company, announced that data from a Clinical Experience Program for its first-in-class, proprietary blood test for Major Depressive Disorder (MDD) will be presented during a poster session entitled Clinician Acceptance and Utility of a Multianalyte Biomarker Panel for Major Depressive Disorder (MDD) Diagnosis.

19 Nov 2010

Scientists solve receptor structure that responds to neurotransmitter dopamine

A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known until now.

19 Nov 2010

Neural differences may help explain prevalence of mental disorders in boys

Many mental health disorders, such as autism and schizophrenia, produce changes in social behavior or interactions. The frequency and/or severity of these disorders is substantially greater in boys than girls, but the biological basis for this difference between the two sexes is unknown.

18 Nov 2010

Children with severe congenital heart defects show high risk of emotional reactivity

Research from the Norwegian Institute of Public Health (NIPH) shows that children with severe congenital heart defects have twice the risk of anxiety at 18 months of age compared to healthy children. Children with mild and moderate heart defects, on the other hand, did not show an increased risk of anxiety.

18 Nov 2010

Study finds association between personality, cognitive ability and neuroendocrinal dysfunction in exhaustion syndrome

Exhaustion syndrome, also called burnout and exhaustion depression, leaves objectively measurable changes in the brain including reduced activity in the frontal lobes and altered regulation of the stress hormone cortisol. This is shown in a new dissertation from Umeå University in Sweden.

18 Nov 2010

BayCare receives SAMHSA grant to develop VFCN network

BayCare Behavioral Health today announced that it has been awarded a grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) in the amount of $200,000 to develop the Veteran, Family and Community Network (VFCN).

18 Nov 2010

CDC data: Adults remain unvaccinated against preventable infectious illnesses

New data from the Centers for Disease Control and Prevention (CDC) show that adults remain largely unvaccinated against preventable infectious illnesses.

18 Nov 2010

Dim light at night linked to depression

Exposure to even dim light at night is enough to cause physical changes in the brains of hamsters that may be associated with depression, a new study shows.

18 Nov 2010

Health Net partners with DoD for Major Depression Disease Management Program

Health Net Federal Services, LLC, part of the Government Contracts segment of Health Net, Inc. (NYSE:HNT), today announced its Major Depression Disease Management Program established in partnership with the Department of Defense (DoD) for TRICARE beneficiaries, ages 18-64. TRICARE is the DoD's health care plan for active duty and retired service members and their families.

18 Nov 2010

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

Naurex Inc., a company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported that data presented at Neuroscience 2010 show that GLYX-13, its clinical-stage candidate for the treatment of depression, shares key mechanistic features associated with the antidepressant efficacy of the NMDA receptor antagonist ketamine.

18 Nov 2010

PerformRx awarded pharmacy benefit management contract by California DGS

PerformRx, a full-service pharmacy benefits management company, today announced it has been awarded the pharmacy benefit management contract by the California Department of General Services (DGS). Chosen as the result of a competitive RFP process, PerformRx will help the California Department of General Services provide efficient pharmacy benefit management services to portions of the state's population covered by DGS's statewide pharmaceutical program.

18 Nov 2010

Children's heart disease affects mental health of mothers

Mothers of children with severe heart disease are more likely to suffer from anxiety and depression than mothers of healthy children, even once any medical interventions are over.

18 Nov 2010

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.

18 Nov 2010

Study finds gender differences linked to gaming and health risks associated with problematic gaming

A new study on gaming and health in adolescents, conducted by researchers at Yale School of Medicine, found some significant gender differences linked to gaming as well as important health risks associated with problematic gaming. Published today in the journal Pediatrics, the study is among the first and largest to examine possible health links to gaming and problematic gaming in a community sample of adolescents.

17 Nov 2010

Video game-based technologies allow new insight into memory, perception and motor control

New tools inspired by video games are revealing how the brain senses and responds to its surroundings, finds new human and animal research. Taking advantage of state-of-the art technologies to track and mimic real-life environments, these studies show with new detail how the brain navigates, identifies, and remembers a setting. In additional human research, scientists apply these same technological advances to help people who have experienced strokes regain skills.

17 Nov 2010

Depression linked to risky sexual behaviours among young South Africans

University of Alberta research has discovered a strong link between depression and risky sexual behaviours such as improper condom use, transactional sex and relationship violence among young people in South Africa.

17 Nov 2010

Mental Health News and Research

Latest Mental Health News and Research

Substance abuse treatment facilities offering nicotine replacement therapy increased by 6%: Report

SAMHSA: 4.8% U.S. adults suffer from serious mental illness

Illness perception related to concurrent depression symptoms: Research

Experts formulate research related to psychological adjustment and traumatic brain injury

Ridge announces data from Clinical Experience Program on blood test for MDD disorder

Scientists solve receptor structure that responds to neurotransmitter dopamine

Neural differences may help explain prevalence of mental disorders in boys

Children with severe congenital heart defects show high risk of emotional reactivity

Study finds association between personality, cognitive ability and neuroendocrinal dysfunction in exhaustion syndrome

BayCare receives SAMHSA grant to develop VFCN network

CDC data: Adults remain unvaccinated against preventable infectious illnesses

Dim light at night linked to depression

Health Net partners with DoD for Major Depression Disease Management Program

Naurex's antidepressant shares efficacy mechanisms with NMDA receptor antagonist ketamine

PerformRx awarded pharmacy benefit management contract by California DGS

Children's heart disease affects mental health of mothers

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Study finds gender differences linked to gaming and health risks associated with problematic gaming

Video game-based technologies allow new insight into memory, perception and motor control

Depression linked to risky sexual behaviours among young South Africans

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Mental Health News and Research

Latest Mental Health News and Research

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in